NCT05413616

Brief Summary

This project aims to improve physical performance in older patients, by offering a personalized combined nutritional intervention with a physical activity training program. The intervention starts at hospital admittance and is continued after discharge in the home care setting, supported by an e-health application.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Jul 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Jul 2022Jul 2027

First Submitted

Initial submission to the registry

May 19, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 10, 2022

Completed
24 days until next milestone

Study Start

First participant enrolled

July 4, 2022

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

July 24, 2025

Status Verified

July 1, 2025

Enrollment Period

4.3 years

First QC Date

May 19, 2022

Last Update Submit

July 22, 2025

Conditions

Keywords

nutritionproteinexercisesarcopeniaolder peoplevitamin D

Outcome Measures

Primary Outcomes (1)

  • Change in Timed Up & Go

    TUG

    Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.

Secondary Outcomes (15)

  • Change in Short Physical Performance Battery

    Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.

  • Change in muscle strength

    Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.

  • Change in muscle mass

    Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.

  • Change in nutritional status

    Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.

  • Change in nutritional intake (energy, protein).

    Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.

  • +10 more secondary outcomes

Study Arms (2)

Standard care

NO INTERVENTION

FITFOOD lifestyle intervention

EXPERIMENTAL

Lifestyle intervention consisting of both a nutritional and exercise intervention.

Behavioral: FITFOOD lifestyle intervention

Interventions

Lifestyle intervention with a nutritional and exercise component.

FITFOOD lifestyle intervention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Aged ≥65 years
  • Living within the Nijmegen area (within 40km)
  • Admitted to clinical ward of Radboudumc or CWZ
  • Understanding and speaking of the Dutch language
  • Mentally competent
  • Signed informed consent

You may not qualify if:

  • Complete use of tube feeding or parenteral nutrition
  • Renal insufficiency (MDRD-GFR \< 30ml/min)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sabien van Exter

Nijmegen, Gelderland, 6531DK, Netherlands

RECRUITING

Related Publications (1)

  • van Exter SH, Koenders N, van der Wees PJ, Drenth JPH, van den Berg MGA. Lessons learned from a combined, personalized lifestyle intervention in hospitalized patients at risk for sarcopenia: a feasibility study. Disabil Rehabil. 2025 Jul;47(14):3679-3686. doi: 10.1080/09638288.2024.2426685. Epub 2024 Nov 12.

MeSH Terms

Conditions

AtrophyMotor ActivitySarcopenia

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsBehaviorMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2022

First Posted

June 10, 2022

Study Start

July 4, 2022

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

July 1, 2027

Last Updated

July 24, 2025

Record last verified: 2025-07

Locations